CN112480191A - Separation and purification method of monomer A and B of dysphagia - Google Patents
Separation and purification method of monomer A and B of dysphagia Download PDFInfo
- Publication number
- CN112480191A CN112480191A CN202011373957.2A CN202011373957A CN112480191A CN 112480191 A CN112480191 A CN 112480191A CN 202011373957 A CN202011373957 A CN 202011373957A CN 112480191 A CN112480191 A CN 112480191A
- Authority
- CN
- China
- Prior art keywords
- dichloromethane
- dysphagia
- silica gel
- methanol
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000178 monomer Substances 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 26
- 238000000746 purification Methods 0.000 title claims abstract description 19
- 238000000926 separation method Methods 0.000 title claims abstract description 19
- 208000019505 Deglutition disease Diseases 0.000 title abstract description 48
- 150000001875 compounds Chemical class 0.000 claims abstract description 22
- 229930182470 glycoside Natural products 0.000 claims abstract description 15
- 150000002338 glycosides Chemical class 0.000 claims abstract description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920005989 resin Polymers 0.000 claims abstract description 13
- 239000011347 resin Substances 0.000 claims abstract description 13
- 239000000741 silica gel Substances 0.000 claims abstract description 11
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 11
- 238000010898 silica gel chromatography Methods 0.000 claims abstract description 11
- 238000001179 sorption measurement Methods 0.000 claims abstract description 10
- 238000004440 column chromatography Methods 0.000 claims abstract description 8
- 239000012535 impurity Substances 0.000 claims abstract description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 114
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 93
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 60
- 239000011259 mixed solution Substances 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000003480 eluent Substances 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 241000219000 Populus Species 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 5
- 239000000287 crude extract Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 2
- 229920005990 polystyrene resin Polymers 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 5
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 235000009566 rice Nutrition 0.000 abstract description 3
- 241000209094 Oryza Species 0.000 abstract 2
- 238000002481 ethanol extraction Methods 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 12
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 10
- 238000001514 detection method Methods 0.000 description 9
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 8
- TUUXBSASAQJECY-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1 TUUXBSASAQJECY-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 241000218231 Moraceae Species 0.000 description 5
- -1 octadecylsilyl Chemical group 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 241001456097 Streblus Species 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- 229940126062 Compound A Drugs 0.000 description 3
- 230000005526 G1 to G0 transition Effects 0.000 description 3
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 3
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 3
- CTGVBHDTGZUEJZ-UHFFFAOYSA-N Noricaritin Natural products CC(C)(O)CCC1=C(O)C=C(O)C(C(C=2O)=O)=C1OC=2C1=CC=C(O)C=C1 CTGVBHDTGZUEJZ-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 3
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- YSCJAYPKBYRXEZ-HZPINHDXSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-4-[(2s,3r,4s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C(O)=O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YSCJAYPKBYRXEZ-HZPINHDXSA-N 0.000 description 2
- YDZWHGJRWMQCDP-NKILCQAGSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-4-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2s,3r,4 Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YDZWHGJRWMQCDP-NKILCQAGSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000002114 high-resolution electrospray ionisation mass spectrometry Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- XILIYVSXLSWUAI-UHFFFAOYSA-N 2-(diethylamino)ethyl n'-phenylcarbamimidothioate;dihydrobromide Chemical compound Br.Br.CCN(CC)CCSC(N)=NC1=CC=CC=C1 XILIYVSXLSWUAI-UHFFFAOYSA-N 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- IYCPMVXIUPYNHI-UHFFFAOYSA-N Icariside I Natural products C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 IYCPMVXIUPYNHI-UHFFFAOYSA-N 0.000 description 1
- 241001671311 Laurus Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 241000904504 Streblus tonkinensis Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 1
- 229930182721 icariside Natural products 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001896 rotating frame Overhauser effect spectroscopy Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a separation and purification method of a monomer A and a monomer B of dysphagia rice, which takes dysphagia rice leaves as a raw material, and the method comprises the steps of ethanol extraction with specific concentration, macroporous adsorption resin adsorption, silica gel chromatographic column chromatography, and high performance liquid phase preparation C18Purifying by silica gel chromatography column to obtain two new monomer compounds. The method can effectively remove a large amount of impurities in the dysphagia miqueliana, and can obtain two dysphagia miqueliana glycosides at one time, thereby providing a material basis for the activity research of the dysphagia miqueliana glycosides and the development of new medicines with single component.
Description
Technical Field
The invention relates to the technical field of separation and purification of active ingredients of traditional Chinese medicines, in particular to a separation and purification method of monomers A and B of dysphagia.
Background
Choking Miyayan (Streblus tonkinensis) belongs to Moraceae (Moraceae) and belongs to the genus Streblus (Streblus laurus). Belongs to the Moraceae (Moraceae) plant, and belongs to the genus Streblus (Streblus lour). Dysphagia due to the fact that the rice poplar is often used as a folk medicinal plant for treating diseases. Through research in the literature, no report on the chemical components and the biological activity of the miyangjie is found so far. Based on that the dysphagia miqueliana is taken as a medicinal plant commonly used by people, in order to better and deeply research components in the medicinal plant, develop and utilize the plant, a separation and purification process of dysphagia miqueliana glycoside A and B, which has the advantages of high extraction rate, low cost and easy industrial production, is found, and can lay a foundation for the research of the characteristic biological activity of dysphagia miqueliana and provide a premise for the research of structure-activity relationship.
Disclosure of Invention
Aiming at the problem that the separation and purification of the dysphagia-a monomer is not available at present, the invention provides a separation and purification method of dysphagia-a and-B monomers. The method can effectively remove a large amount of impurities in the dysphagia miqueliana, and can obtain two dysphagia miqueliana glycosides at one time, thereby providing a material basis for the activity research of the dysphagia miqueliana glycosides and the development of new medicines with single component.
The technical scheme for realizing the purpose of the invention is as follows:
a separation and purification method of monomer of dysphagia aspergilloside A and B comprises the following steps:
1) extracting dysphagia Miyana leaf with 10-15 mass ratios of 65-75% ethanol water solution, recovering ethanol, and diluting the remaining water with 10 times of distilled water to obtain dysphagia Miyana leaf crude extract water solution;
2) carrying out D101 type macroporous adsorption resin column chromatography on the crude extract aqueous solution obtained in the step 1), after full adsorption, washing with distilled water with 4-6 column volumes to remove unadsorbed impurities, then sequentially eluting with 20-35% ethanol aqueous solutions with 4-6 column volumes, discarding the eluent, then eluting with 38-45% ethanol aqueous solutions with 4-6 volume, and concentrating the eluent to obtain an eluted part rich in the icariside A and B;
3) dissolving the part of the sample eluted by 38% -45% ethanol water solution in the step 2) by using methanol, then carrying out silica gel chromatographic column chromatography, sequentially eluting by using 4-6 column volumes of mixed solution of 3% -10% of dichloromethane and 97% -90% of methanol in volume ratio as eluent, discarding 3% -5% of dichloromethane and 97% -95% of methanol mixed solution eluent, and collecting 10% of dichloromethane and 90% of methanol mixed solution eluent;
4) subjecting the eluate of 10% dichloromethane and 90% methanol mixture collected in step 3) to high performance liquid chromatography C18Performing column chromatography to obtain the icaritin A and B, which are new compounds and have the structural formulas shown as the following formulas respectively:
the extract of the dysphagia miqueliana in the step 1) is prepared by the following method: crushing dysphagia Miyana leaves, adding 65-75% ethanol water solution with 10-15 times of weight of the leaves, heating and refluxing for 2-3 times, concentrating under reduced pressure, and drying to obtain dysphagia Miyana leaf extract.
The macroporous resin in the step 2) is polystyrene resin type macroporous resin.
The model of the macroporous resin in the step 2) is D101, the preferred macroporous resin has large adsorption capacity, easy elution and good adsorption kinetics, and does not adsorb saccharides, proteins, inorganic acids, salts, alkalis and micromolecular hydrophilic organic matters, so that general glycoside substances can be separated from the substances, and a better separation effect can be obtained in a shorter time.
The silica gel chromatographic column in the step 3) is a normal phase silica gel chromatographic column.
The purification process in the step 3) is as follows: eluting with 38% -45% ethanol water solution in step 2), dissolving the sample rich in C and B with a small amount of methanol, performing silica gel column chromatography, and gradient eluting with 4-6 column volumes of mixed solution of 3% -10% dichloromethane and 97% -90% methanol as eluent.
The chromatographic column of the high performance liquid chromatography in the step 4) is a reversed-phase octadecylsilane chemically bonded silica chromatographic column, the specification is 20 x 250mm, the particle size of the filler is 5.0 mu m, the high performance liquid chromatography can be used at a higher temperature and under a lower pH condition, the stationary phase does not collapse, the column effect can be kept for a long time, and the service life of the column is prolonged.
The detection conditions of the high performance liquid chromatography are as follows:
stationary phase: chromatographic column with octadecylsilyl bonded silica gel as filler;
detection wavelength: 230 nm;
flow rate: 2.0-4.0 mL/min;
column temperature: 25-35 ℃;
mobile phase: the method comprises the following steps of (1) eluting with 85-80% of water as a mobile phase A and 15-20% of methanol as a mobile phase B, wherein the proportion of the mobile phase A to the mobile phase B is a volume ratio, and in the preparation process of high performance liquid chromatography, the selection of chromatographic conditions is very important and directly influences the retention time, the separation degree and the like of a substance chromatographic peak; the chromatographic conditions mainly comprise a chromatographic column (comprising filler, column length, column temperature and the like), a mobile phase (comprising components, flow rate and the like), a detector, a detection wavelength, column temperature and the like.
Performing high performance liquid chromatography C on the eluate of the mixture of 10% dichloromethane and 90% methanol collected in step 3) in step 4)18The column chromatography purification process comprises: adding 10% dichloromethane and 90% methanol mixed solution eluate to reverse phase C18Eluting with 15-20% methanol water solution in silica gel chromatographic column to obtain monomeric compounds of icaritin A and icaritin B.
In the technical scheme, the miyan dysphagia is a plant belonging to the genus magpie of the family Moraceae, and the medicinal material part is dry leaves.
The dysphagia oryzae contains not only dysphagia oryzae glycoside, but also flavonoid, alkaloids, saccharides, trace elements and other very complex components, so that separation of the dysphagia oryzae glycoside from other substances is difficult to realize, the content of the dysphagia oryzae glycoside is very low, the structure and the physicochemical properties are very similar, and a plurality of monomers of the dysphagia oryzae glycoside are difficult to obtain at one time by a simple separation method.
According to the method for separating and purifying the dysphagia miyagar monomer in the technical scheme, aiming at the physicochemical properties of each component in dysphagia miyagar, a large amount of impurities in the dysphagia miyagar can be effectively removed, the dysphagia miyagar monomer with higher purity can be obtained, the target preparation of the dysphagia miyagar can be realized, a plurality of dysphagia miyagar with known activity can be obtained at one time, and simultaneously, the trace glycosides are enriched and separated, so that the glycoside library can be enriched continuously, and a material basis is provided for the activity research of glycoside compounds and the development of new drugs with single components.
The method can effectively remove a large amount of impurities in the dysphagia miqueliana, and can obtain two dysphagia miqueliana glycosides at one time, thereby providing a material basis for the activity research of the dysphagia miqueliana glycosides and the development of new medicines with single component.
Drawings
FIG. 1 shows the reverse phases C of C and A of C in the examples18Preparing chromatogram by silica gel column chromatography;
FIG. 2 shows dysphagia A of the example1H NMR spectrum;
FIG. 3 shows dysphagia A of the example13C NMR spectrum;
FIG. 4 shows dysphagia B of the example1H NMR spectrum;
FIG. 5 shows dysphagia B of the example13C NMR spectrum.
Detailed Description
The invention will be further elucidated with reference to the drawings and examples, without however being limited thereto.
Example 1:
a separation and purification method of monomer of dysphagia aspergilloside A and B comprises the following steps:
1) taking 10kg of dry miyan choke leaf, adding 10 times of 65% ethanol water solution (volume ratio) of raw materials by mass ratio, sequentially heating and refluxing for 3 times for 3 hours, 2 hours and 2 hours, combining filtrates, and recovering ethanol under reduced pressure to obtain extract;
2) diluting the extract obtained in the step 1) by 50 times with distilled water, adsorbing the extract by a D101 macroporous adsorption resin chromatographic column, washing and washing by distilled water with 4 column volumes to remove unadsorbed impurities, sequentially eluting by 10% ethanol water solution and 30% ethanol water solution with 4 column volumes, discarding the eluent, eluting by 40% ethanol water solution, and concentrating the eluent to obtain an eluted part rich in the icariin A and B;
3) taking the 40% ethanol eluate obtained in the step 2), performing silica gel column chromatography, sequentially eluting with 4 column volumes of 3% dichloromethane and 97% methanol mixed solution and 10% dichloromethane and 90% methanol mixed solution (volume ratio), discarding 3% dichloromethane and 97% methanol mixed solution (volume ratio) eluate, and collecting 10% dichloromethane and 90% methanol mixed solution eluate;
4) subjecting the eluate of the mixture of 10% dichloromethane and 90% methanol collected in step 3) to reversed phase C18Performing silica gel column chromatography, eluting with water-methanol (80:20) to obtain first compound A (t)R21.80min) and a second compound B (t)R=26.45min)。
In the step 4), the conditions for detecting and monitoring the high performance liquid chromatography are as follows:
stationary phase: chromatographic column with octadecylsilyl bonded silica gel as filler;
a detector: an ultraviolet detector;
detection wavelength: 230 nm;
flow rate: 3.0 mL/min;
column temperature: 25 ℃;
mobile phase: water was 80% for mobile phase a and methanol was 20% for mobile phase B.
By detecting the obtained first monomer compound a and the second monomer compound B under the above-mentioned detection conditions, the purity of the first monomer compound a was 99.5%, and the purity of the second monomer compound B was 99.7%.
Example 2:
a separation and purification method of monomer of dysphagia aspergilloside A and B comprises the following steps:
1) adding 12 times of 73% ethanol water solution (mass ratio) into 10kg of dried miyan dysphagia leaves, sequentially heating and reflux-extracting for 3 times (3 hr, 2 hr, and 2 hr), mixing filtrates, and recovering ethanol under reduced pressure to obtain extract;
2) suspending the extract in 50L water, adsorbing with D101 macroporous adsorbent resin chromatographic column, washing with water, and eluting with 20% and 50% ethanol to obtain 20% and 50% ethanol eluate respectively, wherein the 50% ethanol eluate is used as the extract of Choking leaf of Miyan that is rich in Chongxin A and Chongxin B;
3) collecting 625.0g of 50% ethanol eluate obtained in the step 2), performing silica gel column chromatography, sequentially eluting with 4 column volumes of 4% dichloromethane and 96% methanol mixed solution, 10% dichloromethane and 90% methanol mixed solution, and discarding 4% dichloromethane and 96% methanol mixed solution eluate, and collecting 10% dichloromethane and 90% methanol mixed solution eluate;
4) subjecting the eluate of the mixture of 10% dichloromethane and 90% methanol collected in step 3) to reversed phase C18Performing silica gel column chromatography, eluting with water-methanol (80:20) to obtain first compound A (t)R21.82min) and a second compound B (t)R=26.43min)。
In step 4), the conditions for detection and monitoring by high performance liquid chromatography were the same as in example 1 except that the flow rate was 3.5ml/min and the column temperature was 30 ℃.
By detecting the obtained first monomer compound a and the second monomer compound B under the above-mentioned detection conditions, the purity of the first monomer compound a was 99.2%, and the purity of the second monomer compound B was 99.4%.
Example 3:
a separation and purification method of monomer of dysphagia aspergilloside A and B comprises the following steps:
1) taking 10kg of dry miyan choke leaf, adding 15 times of 75% ethanol water solution (mass ratio of raw materials), sequentially heating and refluxing for 3 times for 3 hours, 2 hours and 2 hours, combining filtrates, and recovering ethanol under reduced pressure to obtain extract;
2) suspending the extract obtained in the step 1) in 50L of water, adsorbing by a D101 macroporous adsorption resin chromatographic column, washing with water, and then eluting with 20% and 50% ethanol to obtain 20% and 50% ethanol eluate respectively, wherein the 50% ethanol eluate is used as the extract of the dysphagia miqueliana leaves rich in dysphagia glycoside A and B;
3) subjecting the 50% ethanol eluate obtained in step 2) to silica gel column chromatography, sequentially discarding the 5% dichloromethane and 95% methanol mixed solution eluate (volume ratio) and 4 column volumes of 5% dichloromethane and 95% methanol mixed solution eluate, 10% dichloromethane and 90% methanol mixed solution eluate, and collecting the 10% dichloromethane and 90% methanol mixed solution eluate;
4) subjecting the eluate of 10% dichloromethane and 90% methanol mixture collected in step 3) to reverse phase C18Performing silica gel column chromatography, eluting with water-methanol (80:20) to obtain first compound A (t)R21.81min) and a second compound B (t)R=26.44min)。
In step 4), the conditions for detection and monitoring by high performance liquid chromatography were the same as in example 1 except that the flow rate was 4.0ml/min and the column temperature was 35 ℃.
By detecting the obtained first monomer compound a and the second monomer compound B under the above-mentioned detection conditions, the purity of the first monomer compound a was 99.6%, and the purity of the second monomer compound B was 99.8%.
As shown in FIG. 1, FIG. 2, FIG. 3, FIG. 4 and FIG. 5, the two obtained monomer compounds are subjected to infrared, mass and nuclear magnetic resonance spectroscopy (R), (B), (C1HNMR、13CNMR、DEPT、1H-1The spectrum techniques of HCOSY, HSQC, HMBC, ROESY), Mass Spectrum (MS) and optical rotation and the like identify the structures of the icariin A and B, which are new compounds, and the physicochemical data of the icariin A and B are shown as follows:
choxoside A [4- (3-hydroxy-but-1-enyl) -3,4-dimethyl-2- (3,4, 5-dihydroxy-6-hydroxymethy-l-tetrahydro-pyran-2-yloxymethyl) -cyclohex-2-enone, strigolycoside A]: colorless oil, dissolved in methanol. HRESIMS (positive) M/z 387.2012[ M + H ]]+,(calc.for C19H31O8,387.2019); 1H-NMR(400MHz CD3OD):δH2.55(2H,dd,J=7.4,6.1Hz,H-5),1.92(2H,t,6.8,H-6),6.26(1H,dd,J=15.9,5.1Hz,H-7),6.37(1H,dd,J=15.9,1.2Hz,H-8),4.44(1H,m,H-9),1.36(3H,m,H-10),1.24(3H,s,H-11),1.24(3H,s,H-12),4.67(1H,d,J=9.7Hz,H-13a),4.24(1H,d,J=9.7Hz,H-13b),4.35(1H,d,J=7.8Hz,H-1′),3.17(1H,t,8.3,H-2′),3.28(1H,m,H-3′),3.28(1H,m,H-4′),3.37(1H,m,H-5′),3.88(1H,dd,J=11.9,2.2Hz,H-6′a),3.70(1H,dd,J=11.9,5.3Hz,H-6′b);13C-NMR(100MHz CD3OD)δC 36.6(C-1),170.0(C-2),130.9(C-3),200.6(C-4,C=O),35.0(C-5),37.6(C-6),143.9(C-7),124.1(C-8),68.8(C-9),23.5(C-10),27.4(C-11),27.4(C-12),64.4(C-13),104.1(C-1′),74.9(C-2′),77.8(C-3′),71.4(C-4′),78.0(C-5′),62.8(C-6′)。
Choxoside B [2- (4-p-Tolyl-pentyloxy) -tetrahydropyran-3, 4,5-triol, striglycoside B]: colorless needle crystals, dissolved in methanol. HRESIMS M/z 355.1766[ M + HCOO]-(calcd For C18H27O7,355.1780). 1H-NMR(400MHz CD3OD):δH 7.07(2H,m,H-2,6),7.06(2H,m,H-3,5),3.75(1H,dt,9.2,6.8,H-10a),3.49(1H,m,H-10b),2.63(1H,dt,12.0,7.2,H-7),2.28(3H,s,C-12),1.63(2H,m,H-8),1.48(2H,m,H-9),1.23(3H,d,7.2,H-11),4.14(1H,d,J=7.6Hz,H-1′),3.14(1H,m,H-2′),3.48(1H,m,H-3′),3.46(1H,m,H-4′),3.82(2H,dd,11.6,5.6,H-5′);13C-NMR(100MHz CD3OD)δC 145.5(C-1),127.9(C-2,6),129.9(C-3,5),136.3(C-4),40.6(C-7),35.7(C-8),29.0(C-9),70.9(C-10),23.0(C-11),21.4(C-12),105.1(C-1′),74.9(C-2′),77.8(C-3′),71.2(C-4′),66.9(C-5′)。
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011373957.2A CN112480191A (en) | 2020-11-30 | 2020-11-30 | Separation and purification method of monomer A and B of dysphagia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011373957.2A CN112480191A (en) | 2020-11-30 | 2020-11-30 | Separation and purification method of monomer A and B of dysphagia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112480191A true CN112480191A (en) | 2021-03-12 |
Family
ID=74937632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011373957.2A Pending CN112480191A (en) | 2020-11-30 | 2020-11-30 | Separation and purification method of monomer A and B of dysphagia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112480191A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10237087A (en) * | 1997-02-27 | 1998-09-08 | Sunstar Inc | New diarylheptanoid-based compound |
US6184367B1 (en) * | 1999-03-19 | 2001-02-06 | Council Of Scientific And Industrial Research | Process for the production of 4-aryl-2 butanols from Taxus wallichiana |
CN101195645A (en) * | 2006-12-06 | 2008-06-11 | 广西师范大学 | Anti-hepatitis B virus magpie kidney tree extract and its extraction process |
CN102112119A (en) * | 2008-06-05 | 2011-06-29 | Rnl生物技术株式会社 | Diaryl hepatonoid-based compound useful as virus inhibitor |
CN102250161A (en) * | 2011-04-12 | 2011-11-23 | 中国医学科学院药用植物研究所 | Irisone derivatives with tyrosinase inhibitory activity as well as preparation method and application thereof |
CN102844323A (en) * | 2009-12-07 | 2012-12-26 | 香港科技大学 | Cdk5 inhibitors and therapeutic uses thereof |
CN105582000A (en) * | 2016-01-12 | 2016-05-18 | 张忠立 | Preparation method of terpenoid and lignan substances in eucommia ulmoides bark or eucommia ulmoides leaves and application of terpenoid and lignan substances in preparation of senile dementia treatment drug |
-
2020
- 2020-11-30 CN CN202011373957.2A patent/CN112480191A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10237087A (en) * | 1997-02-27 | 1998-09-08 | Sunstar Inc | New diarylheptanoid-based compound |
US6184367B1 (en) * | 1999-03-19 | 2001-02-06 | Council Of Scientific And Industrial Research | Process for the production of 4-aryl-2 butanols from Taxus wallichiana |
CN101195645A (en) * | 2006-12-06 | 2008-06-11 | 广西师范大学 | Anti-hepatitis B virus magpie kidney tree extract and its extraction process |
CN102112119A (en) * | 2008-06-05 | 2011-06-29 | Rnl生物技术株式会社 | Diaryl hepatonoid-based compound useful as virus inhibitor |
CN102844323A (en) * | 2009-12-07 | 2012-12-26 | 香港科技大学 | Cdk5 inhibitors and therapeutic uses thereof |
CN102250161A (en) * | 2011-04-12 | 2011-11-23 | 中国医学科学院药用植物研究所 | Irisone derivatives with tyrosinase inhibitory activity as well as preparation method and application thereof |
CN105582000A (en) * | 2016-01-12 | 2016-05-18 | 张忠立 | Preparation method of terpenoid and lignan substances in eucommia ulmoides bark or eucommia ulmoides leaves and application of terpenoid and lignan substances in preparation of senile dementia treatment drug |
Non-Patent Citations (3)
Title |
---|
HEFENG PAN, ET AL.: "Phenolics from inner bark of Pinus sylvestris", 《PHYTOCHEMISTRY》 * |
MEGUMI FURUKAWA, ET AL.: "Monoterpene Glucosides from Ziziphora clinopodioides (Labiatae)", 《CHEM. PHARM. BULL.》 * |
YVES CHAMPAVIER, ET AL.: "Norterpenoid and sesquiterpenoid glucosides from Juniperus phoenicea and Galega officinalis", 《PHYTOCHEMISTRY》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101559088A (en) | Production technique of andrographolide and neoandrographolide, dehydroanddrographolide, oxyandrographolide | |
CN102526315B (en) | Preparation method of extracts of effective fractions of lychee seeds | |
CN104327127B (en) | Method for preparing angroside C, aucubin and harpagide through separation and purification by high-speed countercurrent chromatography | |
CN104262154B (en) | Polyphenolic compound method for preparing monomer in Gnaphalium affine | |
CN105669631B (en) | A kind of potentilla plants extract and the method for therefrom separating four kinds of tanninses compounds | |
JP7305870B2 (en) | Method for producing tetragalloyl glucose | |
WO2012061984A1 (en) | Method for preparing albiflorin and paeoniflorin | |
CN102372754A (en) | Method for preparing specnuezhenide | |
WO2022052394A1 (en) | Method for preparing delphinidin acylated anthocyanin | |
CN1283636C (en) | Separation purification method of catechin monomer | |
CN112480191A (en) | Separation and purification method of monomer A and B of dysphagia | |
CN102920727B (en) | Method for preparing extracts rich in vitexin rhamnoside and vitexin glucoside | |
CN110272459A (en) | Two kinds of noval chemical compounds and its antioxidant activity position in root of Paeonia sinjiangensis | |
CN112608306B (en) | Preparation method and application of saponin A, a flavonoid compound in saponin thorn | |
CN109912582A (en) | The method of mangiferin is extracted from mango leaf | |
CN1307191C (en) | Method for preparing geniposide and genipin-1-β-D-gentiobioside from gardenia fruit | |
CN113440547A (en) | Method for separating and purifying Japanese thistle herb total glycosides by adopting macroporous resin series dynamic axial compression column | |
CN112608356B (en) | A kind of separation and purification method of passion fruit spiro ketone glycoside monomer and its application | |
CN114349808B (en) | Separation and purification method of rabdosia amethystoides saponin A and B monomers and application thereof | |
CN101362768A (en) | Separation and purification method of monomer compound in Angelica dahurica | |
CN112480189B (en) | Separation and purification method of spinosad A and B monomers and application thereof | |
CN1869056A (en) | Method of extracting and separating ginseng saponine mixture from ginseng leaf | |
CN111346195A (en) | A kind of preparation method of grass fruit total flavonoids | |
CN1629175A (en) | A kind of method for preparing kaempferol derivative | |
CN114456138B (en) | Method for separating three coumarin compounds from fingered citron extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210312 |